These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 24479608)

  • 41. Hospital variation and risk factors for bronchopulmonary dysplasia in a population-based cohort.
    Lapcharoensap W; Gage SC; Kan P; Profit J; Shaw GM; Gould JB; Stevenson DK; O'Brodovich H; Lee HC
    JAMA Pediatr; 2015 Feb; 169(2):e143676. PubMed ID: 25642906
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Influencing factors for severity of bronchopulmonary dysplasia in preterm infants].
    Li Y; Wei QF; Pan XN; Meng DH; Wei W; Wu QP
    Zhongguo Dang Dai Er Ke Za Zhi; 2014 Oct; 16(10):1014-8. PubMed ID: 25344182
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of early ambroxol treatment on lung functions in mechanically ventilated preterm newborns who subsequently developed a bronchopulmonary dysplasia (BPD).
    Schmalisch G; Wauer RR; Böhme B
    Respir Med; 2000 Apr; 94(4):378-84. PubMed ID: 10845438
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Analysis of survival and prognostic factors in extremely preterm infants].
    Cui YZ; Zhang QS; He HY; Chen C
    Zhongguo Dang Dai Er Ke Za Zhi; 2014 Jun; 16(6):596-600. PubMed ID: 24927434
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Consequences of delayed surgical closure of patent ductus arteriosus in very premature infants.
    Jaillard S; Larrue B; Rakza T; Magnenant E; Warembourg H; Storme L
    Ann Thorac Surg; 2006 Jan; 81(1):231-4. PubMed ID: 16368371
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mean platelet volume and risk of bronchopulmonary dysplasia and intraventricular hemorrhage in extremely preterm infants.
    Dani C; Poggi C; Barp J; Berti E; Fontanelli G
    Am J Perinatol; 2011 Aug; 28(7):551-6. PubMed ID: 21404166
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Epidemiology of bronchopulmonary dysplasia.
    Van Marter LJ
    Semin Fetal Neonatal Med; 2009 Dec; 14(6):358-66. PubMed ID: 19783238
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Associated factors to extubation failure of neonates and infants with bronchopulmonary dysplasia].
    Tapia-Rombo CA; Hernández-Gutiérrez AL
    Rev Invest Clin; 2012; 64(3):262-74. PubMed ID: 23045949
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A multicenter, randomized, controlled trial of lucinactant versus poractant alfa among very premature infants at high risk for respiratory distress syndrome.
    Sinha SK; Lacaze-Masmonteil T; Valls i Soler A; Wiswell TE; Gadzinowski J; Hajdu J; Bernstein G; Sanchez-Luna M; Segal R; Schaber CJ; Massaro J; d'Agostino R;
    Pediatrics; 2005 Apr; 115(4):1030-8. PubMed ID: 15805381
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evidence-Based Pharmacologic Therapies for Prevention of Bronchopulmonary Dysplasia: Application of the Grading of Recommendations Assessment, Development, and Evaluation Methodology.
    Jensen EA; Foglia EE; Schmidt B
    Clin Perinatol; 2015 Dec; 42(4):755-79. PubMed ID: 26593077
    [TBL] [Abstract][Full Text] [Related]  

  • 51. High versus standard dose caffeine for apnoea: a systematic review.
    Vliegenthart R; Miedema M; Hutten GJ; van Kaam AH; Onland W
    Arch Dis Child Fetal Neonatal Ed; 2018 Nov; 103(6):F523-F529. PubMed ID: 29437799
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Caffeine and brain development in very preterm infants.
    Doyle LW; Cheong J; Hunt RW; Lee KJ; Thompson DK; Davis PG; Rees S; Anderson PJ; Inder TE
    Ann Neurol; 2010 Nov; 68(5):734-42. PubMed ID: 21031585
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Impact of providing vitamin A to the routine pulmonary care of extremely low birth weight infants.
    Moreira A; Caskey M; Fonseca R; Malloy M; Geary C
    J Matern Fetal Neonatal Med; 2012 Jan; 25(1):84-8. PubMed ID: 21740337
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Decreased incidence of bronchopulmonary dysplasia after early management changes, including surfactant and nasal continuous positive airway pressure treatment at delivery, lowered oxygen saturation goals, and early amino acid administration: a historical cohort study.
    Geary C; Caskey M; Fonseca R; Malloy M
    Pediatrics; 2008 Jan; 121(1):89-96. PubMed ID: 18166561
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A controlled trial of synthetic surfactant in infants weighing 1250 g or more with respiratory distress syndrome. The American Exosurf Neonatal Study Group I, and the Canadian Exosurf Neonatal Study Group.
    Long W; Corbet A; Cotton R; Courtney S; McGuiness G; Walter D; Watts J; Smyth J; Bard H; Chernick V
    N Engl J Med; 1991 Dec; 325(24):1696-703. PubMed ID: 1944470
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cord blood fibroblast growth factor-10 as a possible predictor of bronchopulmonary dysplasia in preterm infants.
    Mohamed WA; Aseeri MA
    J Neonatal Perinatal Med; 2014 Jan; 7(2):101-5. PubMed ID: 25104125
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Caffeine for apnea of prematurity.
    Hand IL; Noble LM
    N Engl J Med; 2006 Aug; 355(9):959; author reply 959-60. PubMed ID: 16948188
    [No Abstract]   [Full Text] [Related]  

  • 58. Outcome of patent ductus arteriosus ligation in premature infants in the East of England: a prospective cohort study.
    Kang SL; Samsudin S; Kuruvilla M; Dhelaria A; Kent S; Kelsall WA
    Cardiol Young; 2013 Oct; 23(5):711-6. PubMed ID: 23164413
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Bubble nasal CPAP, early surfactant treatment, and rapid extubation are associated with decreased incidence of bronchopulmonary dysplasia in very-low-birth-weight newborns: efficacy and safety considerations.
    Friedman CA; Menchaca RC; Baker MC; Rivas CK; Laberge RN; Rios EH; Haider SH; Romero EJ; Eason EB; Fraley JK; Woldesenbet M
    Respir Care; 2013 Jul; 58(7):1134-42. PubMed ID: 23106970
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Role of antioxidant nutrients and lipid peroxidation in premature infants with respiratory distress syndrome and bronchopulmonary dysplasia.
    Falciglia HS; Johnson JR; Sullivan J; Hall CF; Miller JD; Riechmann GC; Falciglia GA
    Am J Perinatol; 2003 Feb; 20(2):97-107. PubMed ID: 12660915
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.